Compare UFPT & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UFPT | ETON |
|---|---|---|
| Founded | 1963 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1996 | 2018 |
| Metric | UFPT | ETON |
|---|---|---|
| Price | $283.61 | $51.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $355.00 | $71.50 |
| AVG Volume (30 Days) | 76.8K | ★ 378.5K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.44 | N/A |
| EPS | ★ 4.92 | 0.41 |
| Revenue | ★ $602,797,000.00 | $79,950,000.00 |
| Revenue This Year | $9.13 | $87.26 |
| Revenue Next Year | $6.27 | $47.21 |
| P/E Ratio | ★ $57.86 | $124.20 |
| Revenue Growth | 19.50 | ★ 104.94 |
| 52 Week Low | $173.86 | $14.27 |
| 52 Week High | $338.71 | $66.37 |
| Indicator | UFPT | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 44.07 | 46.36 |
| Support Level | $283.22 | $48.58 |
| Resistance Level | $306.24 | $57.00 |
| Average True Range (ATR) | 9.91 | 2.49 |
| MACD | -1.20 | 0.28 |
| Stochastic Oscillator | 16.06 | 41.63 |
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.